Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
12 December, 2017 04:26 IST
Zydus Cadila gets Mexican regulatory authority's nod for Lipaglyn
Source: IRIS | 13 Nov, 2017, 11.41AM
Comments  |  Post Comment

Zydus announced that the Mexico regulatory authority COFEPRIS (Federal Commission for the Protection Against Sanitary Risk), has granted marketing approval to commercialize Lipaglyn™ (Saroglitazar Magnesium) in Mexico for the treatment of Dyslipidemia in patients with diabetes mellitus type 2 and Hypertriglyceridemia in patients with diabetes mellitus type 2 not controlled by statins.
 
Elevated triglycerides and insulin resistance are two key components of the metabolic syndrome, which medical science believes are responsible for diseases like hypertriglyceridemia, diabetic dyslipidemia or Non-Alcoholic Steatohepatitis disease (NASH). Increased triglyceride accumulation in the liver can also lead to inflammation, fibrosis, cirrhosis and liver failure, a serious medical condition known as NAFLD or NASH. Additionally, Zydus is currently evaluating Saroglitazar in several clinical trials for treating liver conditions like NASH and Primary Biliary Cholangitis (PBC).
 
''Saroglitazar is an important scientific and medical breakthrough in our effort to develop medicines for patients suffering from hypertriglyceridemia and diabetic dyslipidemia,'' said Pankaj Patel, Chairman, Zydus Group, and added, ''This approval of Saroglitazar in Mexico is a major milestone for the company.''

Shares of the company declined Rs 27.65, or 5.78%, to trade at Rs 451.00. The total volume of shares traded was 51,256 at the BSE (11.17 a.m., Monday).



Cadila Healthcare Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Company Update
Tata Motors to increase prices of passenger vehicles by 25K - 11-Dec-2017 13:30
Suven Life Sciences secures product patents in India & USA - 11-Dec-2017 11:08
Alembic Pharma's arm gets fast track designation for RP6530 - 11-Dec-2017 11:05
IL&FS Engineering bags order worth Rs 2.15 bn - 11-Dec-2017 10:33
Raminfo bags contract from Rajcom Info Services - 11-Dec-2017 10:25
Glenmark Pharma starts trial of investigational immuno-oncology agent GBR 1342 - 08-Dec-2017 10:45
TVS Motor acquires 14.78% stake in Ultraviolette Automotive - 08-Dec-2017 10:18
Emami to acquire 30% stake in Helios Lifestyle - 08-Dec-2017 10:04
Cyient enters into global alliance with EA Tech - 07-Dec-2017 15:35
SSWL expects 11% growth in order book in Q4FY18 - 07-Dec-2017 11:57
Tata Motors reports JLR sales at 52,332 units in Nov'17 - 07-Dec-2017 11:53
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer